One Drug Wins and Another Fails for Long COVID Fatigue

(MedPage Today) -- The antidepressant fluvoxamine delivered clinically relevant reductions in long COVID fatigue, but the diabetes drug metformin didn't outdo placebo, according to the randomized REVIVE-TOGETHER trial. Among 399 adults with long...
Source
MedPage Today
Opens original article in a new tab



